Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

424.04 1.95 +0.46%
Market cap
$92.2B
P/E
18.8×
Fwd P/E
20.3×
Dividend yield
1.62%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. 8-K filed Jun 10, 2026

Period ended Jun 10, 2026 · Filed · accepted 6:01 AM ET · Document on sec.gov · Filing index

7.01 Regulation FD disclosure